The insider sales are small in absolute and relative terms (<0.1% of market cap) and not uncommon for mid-level executives at biotech firms. No immediate red flag, but monitor for additional selling or absence of buying ahead of clinical data readouts.
Price Chart
Executive Summary
Two senior executives at Sangamo Therapeutics — the Chief Development Officer and Head of Research & Technology — sold shares in the open market, collectively disposing of $107,000 worth of stock within a 7-day window. The sales represent less than 0.1% of the company’s $107M market cap and align with recent routine insider selling.
Key Financial Metrics
Key Facts
- SVP Chief Development Officer sold $89,184 worth of shares on April 21, 2026
- Head of Research & Technology sold $17,694 worth of shares on April 22, 2026
- Both transactions were open-market sales (not related to grants, taxes, or derivatives)
- Total cluster value: $107,000, representing 0.1% of market cap
Financial Impact
$107,000 in open-market insider selling over 7 days
Risk Factors
- Concentrated selling by R&D leadership could signal lack of confidence in pipeline progress
- Biotech stocks are sensitive to insider sentiment, especially near catalyst events
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SGMO-1776974870221 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 1, 2026 13w ago | 8-K | $0.0740 awaiting T+20 | awaiting T+20 | — | — |
Apr 29, 2026 22w ago | 8-K | $0.1300 $0.2000 | ▼ −53.85% | ▼ −48.39% | — |
Apr 21, 2026 23w ago | Insider Cluster | $0.2600 $0.1300 | ▼ −50.00% | ▼ −54.91% | — |
Mar 30, 2026 26w ago | Press Release | $0.2500 $0.1387 | ▼ −44.52% | ▼ −53.94% | — |
Mar 19, 2026 28w ago | Press Release | $0.3300 $0.2700 | ▼ −18.18% | ▼ −27.50% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access